# Sumitomo Dainippon Pharma Co., Ltd. – FDA Inspection, Nov 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/1c86b0d4-989e-4cae-ad7f-4339b52c4cd9
Source feed: FDA_Inspections

> FDA inspection 1113228 of Sumitomo Dainippon Pharma Co., Ltd., November 22, 2019. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1113228
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2019-11-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1277764 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/43625239-cfee-4173-8772-0af3efdf143c)
- FDA Inspection 1064584 - 2018-07-27
- FDA Inspection 990466 - 2016-09-09
- FDA Inspection 853865 - 2013-11-01
- FDA Inspection 770009 - 2012-02-23

Company: https://www.keypedia.com/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
